Global

Aug 01, 2013
Pharmaceutical Executive
As growth in the BRICs and other emerging economies begins to stabilize, companies are finally turning their attention to Africa—a hidden trove of potential that is only as good as you make it.
Aug 01, 2013
Pharmaceutical Executive
By Pharmaceutical Executive Editors
The ?70 billion budget is still subject to final agreement on the European Union's overall spending plans for 2014-2020.
Aug 01, 2013
Pharmaceutical Executive
By Pharmaceutical Executive Editors
With a revision of China's basic drug approval law now underway, a multinational team of experts is proposing major changes to make the country a world class player in innovation.
May 01, 2013
Pharmaceutical Executive
By Pharmaceutical Executive Editors
Patent expiries dampen revenues for some of the biggest Big Pharma, but growth continues unabated for a few nimble "stealth" players moving steadily up the list.
May 01, 2013
Pharmaceutical Executive
By Pharmaceutical Executive Editors
Value-based pricing in the United Kingdom is getting closer, but it remains out of focus.
Apr 01, 2013
Pharmaceutical Executive
By Pharmaceutical Executive Editors
The European Union's attempt to update its transparency rules sparks new debate.
Mar 01, 2013
Pharmaceutical Executive
By Pharmaceutical Executive Editors
European Commision blocks the authorization of a life-saving liver drug outside of France.
Mar 01, 2013
Pharmaceutical Executive
By Pharmaceutical Executive Editors
Chinese policies are to pose new opportunities and challenges for Big Pharma companies active in the country.
Feb 01, 2013
Pharmaceutical Executive
By Pharmaceutical Executive Editors
After a decade of strife, the dialogue between industry and government appears to have entered a positive new phase. Julian Upton reports.
Jan 01, 2013
Pharmaceutical Executive
By Pharmaceutical Executive Editors
Promoting the merits of private-sector drug innovation is no easy task—just ask the UK's Office of Health Economics, with a record 50 years of engagement around the hard policy questions that ultimately drive success in the pharmaceutical marketplace.
native1_300x100
lorem ipsum